NCT06126731 2025-11-24
Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
Institute of Cancer Research, United Kingdom
CR-CSSS Champlain-Charles-Le Moyne
Rigshospitalet, Denmark
Radboud University Medical Center
Wake Forest University Health Sciences
University of Rochester
Sanofi
SWOG Cancer Research Network